No Data
Beijing Chieftain Control Technology Group: 2025 First Quarter Report
Beijing Chieftain Control Technology Group: Summary of the 2024 Annual Report
Beijing Chieftain Control Technology Group: 2024 Annual Report
Beijing Chieftain Control Engineering Technology (300430.SZ): In the first quarter, the net income was 12.5918 million yuan, a year-on-year decrease of 59.09%.
On April 23, Gelonghui reported that Beijing Chieftain Control Engineering Technology (300430.SZ) announced its first quarter report for 2025, with revenue of 0.189 billion yuan, a year-on-year decrease of 29.42%; net income attributable to shareholders of the listed company was 12.5918 million yuan, a year-on-year decrease of 59.09%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 12.3082 million yuan, a year-on-year decrease of 55.44%; basic EPS was 0.05 yuan.
Beijing Chieftain Control Engineering Technology (300430.SZ): Some downstream customers are involved in the field of Innovative Drugs.
According to Gelonghui on April 18, Beijing Chieftain Control Engineering Technology (300430.SZ) stated on the investor interaction platform that some of its downstream customers are involved in the Innovative Drugs field.
Beijing Chieftain Control Engineering Technology (300430.SZ): will focus on the Brain-computer Interface business as one of the key business areas for future development.
On April 18, Gelonghui stated that Beijing Chieftain Control Engineering Technology (300430.SZ) expressed on the investor interaction platform that with the continuous development of technology and national policy support for Brain-computer Interface, this Business has broad future development prospects. The company is also very Bullish on this sector, so it will focus on developing the Brain-computer Interface Business as one of its key areas of expansion in the future, hoping to seize opportunities for growth.
